Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Understanding Unapproved use of Approved Drugs “Off Label” | U.S. Food & Drug Administration
source: U.S. Food & Drug Administration
Has your healthcare provider ever talked to you about using an FDA-approved drug for an unapproved use (sometimes called an “off-label” use) to treat your disease or medical condition?
It is important to know that before a drug can be approved, a company must submit clinical data and other information to FDA for review. The company must show that the drug is safe and effective for its intended uses. “Safe” does not mean that the drug has no side effects. Instead, it means the FDA has determined the benefits of using the drug for a particular use outweigh the potential risks.
When you are prescribed a drug for its approved use, you can be sure:
• That FDA has conducted a careful evaluation of its benefits and risks for that use.
• The decision to use the drug is supported by strong scientific data.
• There is approved drug labeling for healthcare providers on how to use the drug safely and effectively for that use.
Teprotumumab for Treatment of Thyroid Eye Disease Meets Endpoints in Phase 3 StudyResults from the phase 3 OPTIC study sho...
Randomized Controlled Trial of Rituximab in Patients With Graves’ OrbitopathyContext: Graves' orbitopathy (GO) is a ...
Effects of Selenium on Short-Term Control of Hyperthyroidism due to Graves’ Disease Treated With Methimazole: ...Objective: In spite of previous conflic...
Drug-Like Compound Stops Thyroid Overstimulation in Early NIH StudiesResearchers at the National Institutes o...
Randomized Trial of a Short Course of Preoperative Potassium Iodide in Patients Undergoing Thyroidectomy for Graves&...Background: A short course of potassium...
Horizon Pharma plc Announces Phase 3 Confirmatory Trial Evaluating Teprotumumab (OPTIC) for the Treatment of Active ...Horizon Pharma plc today announced topli...
Comparison of Two Different Regimens of Intravenous Methylprednisolone for Patients With Moderate to Severe and Acti...The intravenous methylprednisolone (iv M...
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.